Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Co-triamterzide(Triamterene/hydrochlorothiazide)
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Co-triamterzide 50mg/25mg tablets
0202040H0AAAAAA
|
Triamterene/hydrochlorothiazide | Co-triamterzide(Triamterene/hydrochlorothiazide) | Cardiovascular System | 1 |
|
Dyazide 50mg/25mg tablets
0202040H0BBAAAA
|
Dyazide | Co-triamterzide(Triamterene/hydrochlorothiazide) | Cardiovascular System | No data available |
|
Triam-Co 50mg/25mg tablets
0202040H0BCAAAA
|
Triam-Co | Co-triamterzide(Triamterene/hydrochlorothiazide) | Cardiovascular System | No data available |
|
Triamaxco 50mg/25mg tablets
0202040H0BDAAAA
|
Triamaxco 50/25 | Co-triamterzide(Triamterene/hydrochlorothiazide) | Cardiovascular System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.